Cochrane for Physicians: Putting Evidence Into Practice

Use of Niacin for Primary or Secondary Prevention of Cardiovascular or Cerebrovascular Events

Joseph R. Yancey, MD; Jeanmarie B. Rey, MD

Disclosures

Am Fam Physician. 2018;97(7):436-437. 

In This Article

Evidence-based Answer

Prescription niacin (nicotinic acid, vitamin B3) does not reduce myocardial infarctions, strokes, or overall mortality when used for primary or secondary prevention.[1] (Strength of Recommendation: A, based on consistent, good-quality patient-oriented evidence.)

processing....